APA Zitierstil

Oostindie, S. C., van der Horst, H. J., Kil, L. P., Strumane, K., Overdijk, M. B., van den Brink, E. N., . . . Breij, E. C. W. (2020). DuoHexaBody-CD37(®), a novel biparatopic CD37 antibody with enhanced Fc-mediated hexamerization as a potential therapy for B-cell malignancies. Blood Cancer J.

Chicago Zitierstil

Oostindie, Simone C., et al. "DuoHexaBody-CD37(®), a Novel Biparatopic CD37 Antibody With Enhanced Fc-mediated Hexamerization As a Potential Therapy for B-cell Malignancies." Blood Cancer J 2020.

MLA Zitierstil

Oostindie, Simone C., et al. "DuoHexaBody-CD37(®), a Novel Biparatopic CD37 Antibody With Enhanced Fc-mediated Hexamerization As a Potential Therapy for B-cell Malignancies." Blood Cancer J 2020.

Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.